Literature DB >> 9188555

Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

W Maury1, S Perryman, J L Oaks, B K Seid, T Crawford, T McGuire, S Carpenter.   

Abstract

The role of in vivo long terminal repeat (LTR) sequence variation of the lentivirus equine infectious anemia virus (EIAV) has not been explored. In this study, we investigated the heterogeneity found in the LTR sequences from seven EIAV-seropositive horses: three horses with clinical disease and four horses without any detectable signs of disease. LTR sequences were targeted in this study because the LTR U3 enhancer region of tissue culture-derived isolates has been identified as one of the few hypervariable regions of the EIAV genome. Furthermore, LTR variation may regulate EIAV expression in vivo. Both intra- and interanimal sequence variations were investigated. The intra-animal variation was low in seropositive, healthy horses (on average 0.44%). Intra-animal variation was consistently higher in clinically ill horses (0.99%), suggesting that greater numbers of quasispecies of EIAV are present when active virus replication is ongoing. Interanimal comparisons of consensus sequences generated from each horse demonstrated that the enhancer region is a hotspot of sequence variation in vivo. Thirty-seven of the 83 nucleotides that compose the U3 enhancer region were variable between the different in vivo-derived LTRs. The remainder of the LTR that was analyzed was more conserved, 8 of 195 nucleotide positions being variable. Results of electrophoretic mobility shift assays demonstrated that some nucleotide substitutions that occurred in the enhancer region eliminated or altered transcription factor binding motifs that are known to be important for EIAV LTR expression. These data suggested that the selective pressures exerted on the EIAV LTR enhancer sequences are different from those exerted on the remainder of the LTR. Our findings are consistent with the possibility that enhancer sequence hypervariability can alter expression of the virus in tissue macrophages and therefore contribute to clinical disease in infected horses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188555      PMCID: PMC191723          DOI: 10.1128/JVI.71.7.4929-4937.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Human infection by genetically diverse SIVSM-related HIV-2 in west Africa.

Authors:  F Gao; L Yue; A T White; P G Pappas; J Barchue; A P Hanson; B M Greene; P M Sharp; G M Shaw; B H Hahn
Journal:  Nature       Date:  1992-08-06       Impact factor: 49.962

Review 2.  DNA polymerase fidelity and the polymerase chain reaction.

Authors:  K A Eckert; T A Kunkel
Journal:  PCR Methods Appl       Date:  1991-08

3.  Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus.

Authors:  M Bakhanashvili; A Hizi
Journal:  Biochemistry       Date:  1993-07-27       Impact factor: 3.162

4.  Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant.

Authors:  D S Threadgill; W K Steagall; M T Flaherty; F J Fuller; S T Perry; K E Rushlow; S F Le Grice; S L Payne
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

5.  Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.

Authors:  J Louwagie; F E McCutchan; M Peeters; T P Brennan; E Sanders-Buell; G A Eddy; G van der Groen; K Fransen; G M Gershy-Damet; R Deleys
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

6.  Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequencies.

Authors:  M Bakhanashvili; A Hizi
Journal:  Biochemistry       Date:  1992-10-06       Impact factor: 3.162

7.  A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor function.

Authors:  J M Walker; W D Bowen; S L Patrick; W E Williams; S W Mascarella; X Bai; F I Carroll
Journal:  Eur J Pharmacol       Date:  1993-01-26       Impact factor: 4.432

8.  Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS.

Authors:  T Kodama; K Mori; T Kawahara; D J Ringler; R C Desrosiers
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR.

Authors:  J L Langemeier; S J Cook; R F Cook; K E Rushlow; R C Montelaro; C J Issel
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  11 in total

1.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

3.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

5.  Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.

Authors:  Wendy Maury; Robert J Thompson; Quentin Jones; Sarahann Bradley; Tara Denke; Prasith Baccam; Matthew Smazik; J Lindsay Oaks
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Variability, recombination, and mosaic evolution of the barley BARE-1 retrotransposon.

Authors:  Carlos M Vicient; Ruslan Kalendar; Alan H Schulman
Journal:  J Mol Evol       Date:  2005-07-18       Impact factor: 2.395

7.  Equine infectious anemia virus is found in tissue macrophages during subclinical infection.

Authors:  J L Oaks; T C McGuire; C Ulibarri; T B Crawford
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.

Authors:  Susan L Payne; Xiao-fang Pei; Bin Jia; Angela Fagerness; Frederick J Fuller
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity.

Authors:  Véronique Goffin; Dominique Demonté; Caroline Vanhulle; Stéphane de Walque; Yvan de Launoit; Arsène Burny; Yves Collette; Carine Van Lint
Journal:  Nucleic Acids Res       Date:  2005-08-01       Impact factor: 16.971

Review 10.  Equine infectious anemia virus in China.

Authors:  Hua-Nan Wang; Dan Rao; Xian-Qiu Fu; Ming-Ming Hu; Jian-Guo Dong
Journal:  Oncotarget       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.